Molnupiravir
Pharmaceutical-grade Molnupiravir (CAS 2349386-89-4), min. 99.0%, supplied wholesale by Zyntex to licensed producers. Oral nucleoside analogue antiviral API for capsules in markets where authorized. CoA and SDS with every lot.
Description
Molnupiravir Product Overview
Molnupiravir (C13H19N3O7) is a white to off-white powder. It is the isobutyrate ester prodrug of the ribonucleoside analogue N4-hydroxycytidine (EIDD-1931), which is the active form in the body.
Pharmaceutical companies use it in hard capsules for oral antiviral treatment. Its regulatory status varies widely: it has been authorized in some countries, while in others, including the EU, a marketing authorization was not granted. Buyers must therefore check the status in their target markets.
Because it acts as a mutagenic nucleoside analogue in viruses, it requires careful occupational handling. Zyntex supplies molnupiravir only to licensed pharmaceutical companies. Other antiviral APIs in our range include Remdesivir and Valganciclovir Hydrochloride.
Key Applications of Molnupiravir
Main application areas:
💊 Capsules
API for oral antiviral capsules.
🌍 Authorized Markets
API for products in countries where it is approved.
🔬 Generic Development
Development and reference material.
🧪 Analytical Use
Reference material for impurity testing.
Molnupiravir Technical Specifications
| Parameter | Standard Value |
|---|---|
| Product Name | Molnupiravir |
| CAS Number | 2349386-89-4 |
| Molecular Formula / Weight | C13H19N3O7 / 329.31 g/mol |
| Assay / Purity | Min. 99.0% |
| Appearance | White to off-white powder |
| Documents | CoA and SDS with every lot |
⚠️ Safety & Handling: Pharmacologically active substance suspected of causing genetic defects and of damaging fertility or the unborn child. Handle in contained systems with gloves, eye protection and respiratory protection. Store in tightly closed containers in a cool, dry place. Always consult the Safety Data Sheet (SDS) for full classification and handling instructions.
Frequently Asked Questions
Is molnupiravir approved everywhere?
No. It is authorized in some countries but not in others, including the EU. Buyers must check the regulatory status in their markets.
Who can purchase this API?
It is supplied only to pharmaceutical companies holding the licenses required for API purchase and use in their country.
How can I get a price and documents?
Prices depend on quantity, packaging and destination. Contact us with your required volume to receive a quotation together with the CoA and SDS.
